Genetic deficiency or pharmacological inhibition of miR-33 protects from kidney fibrosis

Previous work has reported the important links between cellular bioenergetics and the development of chronic kidney disease, highlighting the potential for targeting metabolic functions to regulate disease progression. More recently, it has been shown that alterations in fatty acid oxidation (FAO) c...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:JCI Insight
Main Authors: Price, Nathan L., Miguel, Verónica, Ding, Wen, Singh, Abhishek K., Malik, Shipra, Rotllan, Noemi, Moshnikova, Anna, Toczek, Jakub, Zeiss, Caroline, Sadeghi, Mehran M., Arias, Noemi, Baldán, Ángel, Andreev, Oleg A., Rodríguez-Puyol, Diego, Bahal, Raman, Reshetnyak, Yana K., Suárez, Yajaira, Fernández-Hernando, Carlos, Lamas, Santiago
Format: Artigo
Jezik:Inglês
Izdano: American Society for Clinical Investigation 2019
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6948871/
https://ncbi.nlm.nih.gov/pubmed/31613798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.131102
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki